| WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research DN Slenter, M Kutmon, K Hanspers, A Riutta, J Windsor, N Nunes, ... Nucleic acids research 46 (D1), D661-D667, 2018 | 943 | 2018 |
| WikiPathways: connecting communities M Martens, A Ammar, A Riutta, A Waagmeester, DN Slenter, K Hanspers, ... Nucleic acids research 49 (D1), D613-D621, 2021 | 680 | 2021 |
| Adverse outcome pathways: opportunities, limitations and open questions M Leist, A Ghallab, R Graepel, R Marchan, R Hassan, SH Bennekou, ... Archives of Toxicology 91, 3477-3505, 2017 | 359 | 2017 |
| COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms M Ostaszewski, A Niarakis, A Mazein, I Kuperstein, R Phair, ... Molecular systems biology 17 (10), e10387, 2021 | 90 | 2021 |
| WikiPathways 2024: next generation pathway database A Agrawal, H Balcı, K Hanspers, SL Coort, M Martens, DN Slenter, ... Nucleic acids research 52 (D1), D679-D689, 2024 | 85 | 2024 |
| Intratumoral combination therapy with poly (I: C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity C Anfray, F Mainini, E Digifico, A Maeda, M Sironi, M Erreni, A Anselmo, ... Journal for immunotherapy of cancer 9 (9), 2021 | 69 | 2021 |
| Introducing WikiPathways as a data-source to support adverse outcome pathways for regulatory risk assessment of chemicals and nanomaterials M Martens, T Verbruggen, P Nymark, R Grafström, LD Burgoon, H Aladjov, ... Frontiers in Genetics 9, 661, 2018 | 45 | 2018 |
| Metabolism and toxicity of fluorine compounds JL Kyzer, M Martens Chemical Research in Toxicology 34 (3), 678-680, 2021 | 43 | 2021 |
| Towards a qAOP framework for predictive toxicology-linking data to decisions A Paini, I Campia, MTD Cronin, D Asturiol, L Ceriani, TE Exner, W Gao, ... Computational Toxicology 21, 100195, 2022 | 25 | 2022 |
| Genome-wide strategies identify downstream target genes of chick connective tissue-associated transcription factors M Orgeur, M Martens, G Leonte, S Nassari, MA Bonnin, ST Börno, ... Development 145 (7), dev161208, 2018 | 24 | 2018 |
| Providing adverse outcome pathways from the AOP-wiki in a semantic web format to increase usability and accessibility of the content M Martens, CT Evelo, EL Willighagen Applied In Vitro Toxicology 8 (1), 2-13, 2022 | 20 | 2022 |
| COVID-19 through adverse outcome pathways: Building networks to better understand the disease–3rd CIAO AOP design workshop LA Clerbaux, N Amigó, MJ Amorim, A Bal-Price, SB Leite, A Beronius, ... Altex 39 (2), 322–335, 2022 | 19 | 2022 |
| A strategy towards the generation of testable adverse outcome pathways for nanomaterials S Murugadoss, IV Vrcek, B Pem, K Jagiello, B Judzinska, A Sosnowska, ... Altex-Heidelberg-, 1-13, 2021 | 19 | 2021 |
| Ten simple rules for creating reusable pathway models for computational analysis and visualization K Hanspers, M Kutmon, SL Coort, D Digles, LJ Dupuis, F Ehrhart, F Hu, ... PLoS computational biology 17 (8), e1009226, 2021 | 15 | 2021 |
| A dual transcript-discovery approach to improve the delimitation of gene features from RNA-seq data in the chicken model M Orgeur, M Martens, ST Börno, B Timmermann, D Duprez, S Stricker Biology Open 7 (1), bio028498, 2018 | 11 | 2018 |
| The AOP-DB RDF: Applying FAIR principles to the semantic integration of AOP data using the research description framework HM Mortensen, M Martens, J Senn, T Levey, CT Evelo, EL Willighagen, ... Frontiers in Toxicology 4, 803983, 2022 | 10 | 2022 |
| ELIXIR and Toxicology: a community in development M Martens, R Stierum, EL Schymanski, CT Evelo, R Aalizadeh, H Aladjov, ... F1000Research 10, 2021 | 7 | 2021 |
| A community-driven, openly accessible molecular pathway integrating knowledge on malignant pleural mesothelioma M Martens, F Kreidl, F Ehrhart, D Jean, M Mei, HM Mortensen, A Nash, ... Frontiers in oncology 12, 849640, 2022 | 5 | 2022 |
| Why adverse outcome pathways need to be FAIR C Wittwehr, LA Clerbaux, S Edwards, M Angrish, H Mortensen, A Carusi, ... ALTEX 41 (1), 50, 2024 | 4 | 2024 |
| Linking nanomaterial-induced mitochondrial dysfunction to existing adverse outcome pathways for chemicals S Murugadoss, IV Vrček, A Schaffert, M Paparella, B Pem, A Sosnowska, ... ALTEX-Alternatives to animal experimentation 41 (1), 2024 | 2 | 2024 |
Egon WillighagenTGX, NUTRIM, Maastricht University/NL, ORCID:0000-0001-7542-0286, https://social.edu.nl/@egonwVerified email at maastrichtuniversity.nl
